Abiopharma

🔍 Eisel Catherine (Executive)

Company: LINKBANCORP, Inc. (LNKB)

Report Date: 2026-04-22

Detailed Transactions and Holdings:

• Sold 1,429 shares of Common Stock at $8.71 per share (Direct)
  Date: 2026-04-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,066.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-22 | Code: H | nature_of_ownership: By Spouse's IRA | shares_owned_after: 23,643.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-22 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 7,800.00
• Holds 5,000 shares of Stock Options at $6.58 per share (Derivative)
  Date: 2026-04-22 | Code: H | Expires: 2035-05-23 | Exercise: 2026-05-23 | shares_owned_after: 5,000.00 | Footnotes: F3, F3

Footnotes:

• F1: The 1,429 shares of common stock disposed of represent a portion of the shares issued to the reporting person upon vesting of restricted stock. The shares disposed of were withheld to satisfy the reporting person's tax obligation.
• F2: Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.
• F3: Stock options vest at a rate of 20% per year commencing on May 23, 2025.